Arndt M L, Wu D, Soong Y, Szeto H H
Department of Pharmacology, Cornell University Medical College, New York, NY 10021, USA.
Peptides. 1999;20(4):465-70. doi: 10.1016/s0196-9781(99)00027-3.
This study was undertaken to examine the cardiovascular effects of nociceptin/Orphanin FQ (OFQ). Nociceptin/OFQ (10-300 nmol/kg, IV) stimulates an increase in mean blood pressure (MBP) and heart rate (HR) in chronically catheterized sheep. Pretreatment with phenoxybenzamine (5 mg/kg) attenuated the pressor response, consistent with sympathetically mediated vasoconstriction. Furthermore, the lack of a reflex bradycardia suggests either blunting of the baroreflex by nociceptin/OFQ or direct beta-adrenergic activation. The bradycardic response to norepinephrine (0.6 microg/kg, IV) remained intact after nociceptin/OFQ administration, demonstrating that nociceptin/OFQ does not blunt the baroreflex. Additionally, the increase in HR was completely reversed by pretreatment with propranolol. These data suggest that nociceptin/OFQ plays a role in cardiovascular regulation via sympathetic activation.
本研究旨在探讨孤啡肽/痛敏肽(OFQ)对心血管系统的影响。孤啡肽/痛敏肽(10 - 300 nmol/kg,静脉注射)可使慢性插管绵羊的平均血压(MBP)和心率(HR)升高。用酚苄明(5 mg/kg)预处理可减弱升压反应,这与交感神经介导的血管收缩一致。此外,缺乏反射性心动过缓表明孤啡肽/痛敏肽使压力反射迟钝或直接激活β - 肾上腺素能受体。在给予孤啡肽/痛敏肽后,对去甲肾上腺素(0.6 μg/kg,静脉注射)的心动过缓反应仍保持完整,表明孤啡肽/痛敏肽不会使压力反射迟钝。此外,用普萘洛尔预处理可完全逆转心率升高。这些数据表明孤啡肽/痛敏肽通过交感神经激活在心血管调节中发挥作用。